Topoisomerase

Sigaling Pathway Map

Research Area

  • Inhibitory Selectivity
  • Solubility
Catalog No. Product Name Solubility(25°C)
Water DMSO Alcohol
S1208 Doxorubicin (Adriamycin) HCl 20 mg/mL 100 mg/mL <1 mg/mL
S1225 Etoposide <1 mg/mL 100 mg/mL <1 mg/mL
S1288 Camptothecin <1 mg/mL 3 mg/mL <1 mg/mL
S1231 Topotecan HCl 91 mg/mL 91 mg/mL <1 mg/mL
S1198 Irinotecan <1 mg/mL 7 mg/mL <1 mg/mL
S1228 Idarubicin HCl 5 mg/mL 100 mg/mL <1 mg/mL
S1223 Epirubicin HCl 100 mg/mL 100 mg/mL <1 mg/mL
S2485 Mitoxantrone 2HCl 89 mg/mL 89 mg/mL <1 mg/mL
S3035 Daunorubicin HCl 100 mg/mL 100 mg/mL <1 mg/mL
S1465 Moxifloxacin HCl 60 mg/mL 87 mg/mL <1 mg/mL
S2217 Irinotecan HCl Trihydrate 1 mg/mL 100 mg/mL 7 mg/mL
S4908 SN-38 <1 mg/mL 21 mg/mL <1 mg/mL
S1367 Amonafide <1 mg/mL 57 mg/mL 4 mg/mL
S1787 Teniposide <1 mg/mL 40 mg/mL <1 mg/mL
S1340 Gatifloxacin <1 mg/mL 7 mg/mL <1 mg/mL
S1222 Dexrazoxane HCl (ICRF-187, ADR-529) 60 mg/mL 60 mg/mL <1 mg/mL
S1342 Genistein <1 mg/mL 54 mg/mL 2 mg/mL
S1889 Mitoxantrone <1 mg/mL 88 mg/mL <1 mg/mL
S1940 Levofloxacin 11 mg/mL 24 mg/mL 9 mg/mL
S1393 Pirarubicin <1 mg/mL 7 mg/mL <1 mg/mL
S1464 Marbofloxacin <1 mg/mL 3 mg/mL <1 mg/mL
S2027 Ciprofloxacin <1 mg/mL <1 mg/mL <1 mg/mL
S2492 Novobiocin Sodium 100 mg/mL 100 mg/mL 100 mg/mL
S1756 Enoxacin <1 mg/mL 32 mg/mL <1 mg/mL
S1463 Ofloxacin <1 mg/mL 0.4 mg/mL <1 mg/mL
S1509 Norfloxacin <1 mg/mL 3 mg/mL <1 mg/mL
S1327 Ellagic acid <1 mg/mL 3 mg/mL <1 mg/mL
S2328 Nalidixic acid <1 mg/mL 6 mg/mL <1 mg/mL
S7261 Beta-Lapachone <1 mg/mL 33 mg/mL 10 mg/mL
S4006 Clinafloxacin <1 mg/mL 0.03 mg/mL <1 mg/mL
S4119 Pefloxacin Mesylate Dihydrate 67 mg/mL 9 mg/mL <1 mg/mL
S2064 Balofloxacin <1 mg/mL 5 mg/mL <1 mg/mL
S4591 Nitroxoline <1 mg/mL 38 mg/mL <1 mg/mL
S4604 Levofloxacin hydrate 5 mg/mL 74 mg/mL 10 mg/mL
S2423 (S)-10-Hydroxycamptothecin <1 mg/mL 8 mg/mL <1 mg/mL
S7518 Voreloxin (SNS-595) hydrochloride 1 mg/mL 1 mg/mL <1 mg/mL
S3603 Betulinic acid <1 mg/mL 20 mg/mL 10 mg/mL
S3181 Flumequine <1 mg/mL 3 mg/mL <1 mg/mL

Isoform-specific Inhibitors

Catalog No. Information Product Use Citations Product Validations
S1208

Doxorubicin (Adriamycin) HCl

Doxorubicin (Adriamycin) HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis in tumor cells.

S1225

Etoposide

Etoposide is a semisynthetic derivative of podophyllotoxin, which inhibits DNA synthesis via topoisomerase II inhibition activity.

S1288

Camptothecin

Camptothecin is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM in a cell-free assay. Phase 2.

S1231

Topotecan HCl

Topotecan HCl is a topoisomerase I inhibitor for MCF-7 Luc cells and DU-145 Luc cells with IC50 of 13 nM and 2 nM in cell-free assays, respectively.

S1198

Irinotecan

Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.

S1228

Idarubicin HCl

Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL in a cell-free assay.

S1223

Epirubicin HCl

Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.

S2485

Mitoxantrone 2HCl

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

S3035

Daunorubicin HCl

Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM in a cell-free assay.

S1465

Moxifloxacin HCl

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent.

S2217

Irinotecan HCl Trihydrate

Irinotecan prevents DNA from unwinding by inhibition of topoisomerase 1.

S4908

SN-38

SN-38 is an active metabolite of CPT-11, inhibits DNA topoisomerase I, DNA synthesis and causes frequent DNA single-strand breaks.

S1367

Amonafide

Amonafide produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage. Phase 3.

S1787

Teniposide

Teniposide is a chemotherapeutic medication mainly used in the treatment of childhood acute lymphocytic leukemia (ALL).

S1340

Gatifloxacin

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, and inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

S1222

Dexrazoxane HCl (ICRF-187, ADR-529)

Dexrazoxane HCl (ICRF-187, ADR-529) is an intracellular iron chelator, which decreases the formation of superoxide radicals, used as a cardioprotective agent; also an inhibitor of topoisomerase II

S1342

Genistein

Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.

S1889

Mitoxantrone

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

S1940

Levofloxacin

Levofloxacin is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections.

S1393

Pirarubicin

Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into DNA and interacts with topoisomerase II, used as an antineoplastic agent.

S1464

Marbofloxacin

Marbofloxacin is a potent antibiotic inhibiting bacterial DNA replication.

S2027

Ciprofloxacin

Ciprofloxacin is a fluoroquinolone antibiotic, shows broad and potent antibacterial activity, with MIC90 of 0.024-6 μM.

S2492

Novobiocin Sodium

Novobiocin Sodium is an aminocoumarin antibiotic that targets bacterial DNA gyrase (TopoIV), used to treat susceptible gram positive bacteria.

S1756

Enoxacin

Enoxacin is an oral broad-spectrum fluoroquinolone antibacterial agent by inhibiting bacterial DNA gyrase and topoisomerase IV, used to treat a wide variety of infections.

S1463

Ofloxacin

Ofloxacin is a synthetic broad-spectrum antimicrobial agent.

S1509

Norfloxacin

Norfloxacin is a broad-spectrum antibiotic.

S1327

Ellagic acid

Ellagic acid has antiproliferative and antioxidant property.

S2328

Nalidixic acid

Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase.

S7261

Beta-Lapachone

Beta-Lapachone is a selective DNA topoisomerase I inhibitor, exhibiting no inhibitory activities against DNA topoisomerase II or ligase. Phase 2.

S4006

Clinafloxacin

Clinafloxacin is a fluoroquinolone that inhibits both DNA gyrase and topoisomerase IV dually in Streptococcus pneumoniae.

S4119

Pefloxacin Mesylate Dihydrate

Pefloxacin Mesylate Dihydrate is the third generation of fluoroquinolone class of antibacterials, which inhibits Topoisomerase II activity and DNA replication.

S2064

Balofloxacin

Balofloxacin is a quinolone antibiotic, inhibiting the synthesis of bacterial DNA by interference with the enqyme DNA gyrase.

S4591

Nitroxoline

Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a fluorquinolone that is active against bacterial gyrases.

S4604

Levofloxacin hydrate

Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. It acts by inhibiting DNA gyrase (bacterial topoisomerase II).

S2423

(S)-10-Hydroxycamptothecin

10-Hydroxycamptothecin is a DNA topoisomerase I inhibitor with potent anti-tumor activity.

S7518

Voreloxin (SNS-595) hydrochloride

Voreloxin is a potent Topoisomerase II inhibitor with broad-spectrum anti-tumor activity. Phase 2.

S3603

Betulinic acid

Betulinic acid, a pentacyclic triterpenoid from Syzigium claviflorum, is a inhibitor of HIV-1 with EC50 of 1.4 μ M. Phase 1/2.

S3181

Flumequine

Flumequine is a synthetic chemotherapeutic antibiotic, inhibiting topoisomerase II with IC50 of 15 μM.

Catalog No. Information Product Use Citations Product Validations
S1208

Doxorubicin (Adriamycin) HCl

Doxorubicin (Adriamycin) HCl is an antibiotic agent that inhibits DNA topoisomerase II and induces DNA damage and apoptosis in tumor cells.

S1225

Etoposide

Etoposide is a semisynthetic derivative of podophyllotoxin, which inhibits DNA synthesis via topoisomerase II inhibition activity.

S1288

Camptothecin

Camptothecin is a specific inhibitor of DNA topoisomerase I (Topo I) with IC50 of 0.68 μM in a cell-free assay. Phase 2.

S1231

Topotecan HCl

Topotecan HCl is a topoisomerase I inhibitor for MCF-7 Luc cells and DU-145 Luc cells with IC50 of 13 nM and 2 nM in cell-free assays, respectively.

S1198

Irinotecan

Irinotecan is a topoisomerase I inhibitor for LoVo cells and HT-29 cells with IC50 of 15.8 μM and 5.17 μM, respectively.

S1228

Idarubicin HCl

Idarubicin HCl is a hydrochloride salt form of Idarubicin which is an anthracycline antibiotic and a DNA topoisomerase II (topo II) inhibitor for MCF-7 cells with IC50 of 3.3 ng/mL in a cell-free assay.

S1223

Epirubicin HCl

Epirubicin HCl, a semisynthetic L-arabino derivative of doxorubicin, is an antineoplastic agent by inhibiting Topoisomerase.

S2485

Mitoxantrone 2HCl

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

S3035

Daunorubicin HCl

Daunorubicin HCl inhibits both DNA and RNA synthesis and inhibits DNA synthesis with Ki of 0.02 μM in a cell-free assay.

S1465

Moxifloxacin HCl

Moxifloxacin is a fourth-generation synthetic fluoroquinolone antibacterial agent.

S2217

Irinotecan HCl Trihydrate

Irinotecan prevents DNA from unwinding by inhibition of topoisomerase 1.

S4908

SN-38

SN-38 is an active metabolite of CPT-11, inhibits DNA topoisomerase I, DNA synthesis and causes frequent DNA single-strand breaks.

S1367

Amonafide

Amonafide produces protein-associated DNA-strand breaks through a topoisomerase II-mediated reaction, but does not produce topoisomerase I-mediated DNA cleavage. Phase 3.

S1787

Teniposide

Teniposide is a chemotherapeutic medication mainly used in the treatment of childhood acute lymphocytic leukemia (ALL).

S1340

Gatifloxacin

Gatifloxacin is an antibiotic of the fourth-generation fluoroquinolone family, and inhibits the bacterial enzymes DNA gyrase and topoisomerase IV.

S1222

Dexrazoxane HCl (ICRF-187, ADR-529)

Dexrazoxane HCl (ICRF-187, ADR-529) is an intracellular iron chelator, which decreases the formation of superoxide radicals, used as a cardioprotective agent; also an inhibitor of topoisomerase II

S1342

Genistein

Genistein, a phytoestrogen found in soy products, is a highly specific inhibitor of protein tyrosine kinase (PTK) which blocks the mitogenic effect mediated by EGF on NIH-3T3 cells with IC50 of 12μM or by insulin with IC50 of 19 μM.

S1889

Mitoxantrone

Mitoxantrone is a type II topoisomerase inhibitor with IC50 of 2.0 μM, 0.42 mM for HepG2 and MCF-7/wt cells, respectively.

S1940

Levofloxacin

Levofloxacin is a broad-spectrum antibiotic topoisomerase II and topoisomerase IV inhibitor, used to treat respiratory, urinary tract, gastrointestinal, and abdominal infections.

S1393

Pirarubicin

Pirarubicin is an anthracycline antibiotic, and also a DNA/RNA synthesis inhibitor by intercalating into DNA and interacts with topoisomerase II, used as an antineoplastic agent.

S1464

Marbofloxacin

Marbofloxacin is a potent antibiotic inhibiting bacterial DNA replication.

S2027

Ciprofloxacin

Ciprofloxacin is a fluoroquinolone antibiotic, shows broad and potent antibacterial activity, with MIC90 of 0.024-6 μM.

S2492

Novobiocin Sodium

Novobiocin Sodium is an aminocoumarin antibiotic that targets bacterial DNA gyrase (TopoIV), used to treat susceptible gram positive bacteria.

S1756

Enoxacin

Enoxacin is an oral broad-spectrum fluoroquinolone antibacterial agent by inhibiting bacterial DNA gyrase and topoisomerase IV, used to treat a wide variety of infections.

S1463

Ofloxacin

Ofloxacin is a synthetic broad-spectrum antimicrobial agent.

S1509

Norfloxacin

Norfloxacin is a broad-spectrum antibiotic.

S1327

Ellagic acid

Ellagic acid has antiproliferative and antioxidant property.

S2328

Nalidixic acid

Nalidixic acid is a synthetic 1,8-naphthyridine antimicrobial agent with a limited bacteriocidal spectrum. It is an inhibitor of the A subunit of bacterial DNA gyrase.

S7261

Beta-Lapachone

Beta-Lapachone is a selective DNA topoisomerase I inhibitor, exhibiting no inhibitory activities against DNA topoisomerase II or ligase. Phase 2.

S4006

Clinafloxacin

Clinafloxacin is a fluoroquinolone that inhibits both DNA gyrase and topoisomerase IV dually in Streptococcus pneumoniae.

S4119

Pefloxacin Mesylate Dihydrate

Pefloxacin Mesylate Dihydrate is the third generation of fluoroquinolone class of antibacterials, which inhibits Topoisomerase II activity and DNA replication.

S2064

Balofloxacin

Balofloxacin is a quinolone antibiotic, inhibiting the synthesis of bacterial DNA by interference with the enqyme DNA gyrase.

S4591

Nitroxoline

Nitroxoline is a urinary antibacterial agent active against susceptible gram-positive and gram-negative organisms commonly found in urinary tract infections. It is a fluorquinolone that is active against bacterial gyrases.

S4604

Levofloxacin hydrate

Levofloxacin is a broad-spectrum, third-generation fluoroquinolone antibiotic and optically active L-isomer of ofloxacin with antibacterial activity. It acts by inhibiting DNA gyrase (bacterial topoisomerase II).

S2423

(S)-10-Hydroxycamptothecin

10-Hydroxycamptothecin is a DNA topoisomerase I inhibitor with potent anti-tumor activity.

S7518

Voreloxin (SNS-595) hydrochloride

Voreloxin is a potent Topoisomerase II inhibitor with broad-spectrum anti-tumor activity. Phase 2.

S3603

Betulinic acid

Betulinic acid, a pentacyclic triterpenoid from Syzigium claviflorum, is a inhibitor of HIV-1 with EC50 of 1.4 μ M. Phase 1/2.

S3181

Flumequine

Flumequine is a synthetic chemotherapeutic antibiotic, inhibiting topoisomerase II with IC50 of 15 μM.